Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with Rheumatoid Arthritis based on the 2010 international diagnostic criteria
- People whose condition meets the medical requirements for starting a type of medication called a JAK inhibitor, based on approved guidelines and international recommendations
- People who are able to give their full, written, and signed agreement to participate before the trial begins
Who may not be able to join:
- People who have a medical reason preventing them from taking a type of arthritis medication called a bDMARD
- People whose corticosteroid (steroid) dose has not been stable for at least 4 weeks before joining the trial
- People whose dose of ongoing arthritis medications (such as methotrexate, leflunomide, hydroxychloroquine, cyclosporine, or gold salts) has not been stable for at least 4 weeks before joining the trial
- People who have previously been treated with a JAK inhibitor medication
- People who would not be able to attend follow-up appointments throughout the 6-month study period
- People who are minors, or adults under legal guardianship or court protection, or who are currently detained
- People who are pregnant or breastfeeding
- People who are unwilling to use an effective form of contraception for the full duration of the study
- People who are not enrolled in a social security scheme (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olivier BROCQ, MD, Centre Hospitalier Princesse Grace
Phone: 97 98 99 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
EULAR response criteria between the two groups
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.